NCT00239382View on ClinicalTrials.gov

A Study to Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in Patients With Rheumatoid Arthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 1, 2004

Primary Completion Date

December 1, 2004

Study Completion Date

December 31, 2004

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

Meloxicam ampoule

DRUG

Meloxicam tablet

Trial Locations (8)

100044

People's Hospital, Beijing University, Beijing

100050

Beijing Xuan Wu Hospital, Beijing

200001

Shanghai Renji Hospital, Shanghai

200032

Shanghai Zhongshan Hospital, Shanghai

200052

Shanghai Guanghai Hospital, Shanghai

200443

Shanghai Changhai Hospital, Shanghai

230022

1st Affiliated, Anhui Medical University, Hefei City, Anhui Province

250012

Qilu Hospital, Shang Dong University, Nanzhou

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00239382 - A Study to Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter